Fluorine-18 labeling of peptide nucleic acids

被引:28
作者
Kuhnast, B
Dolle, F
Tavitian, B
机构
[1] CEA, Serv Hosp Frederic Joliot, Dept Rech Med, DSV, F-91401 Orsay, France
[2] CEA, DSV4, INSERM ERM 0103, F-91401 Orsay, France
关键词
fluorine-18; peptide nucleic acid; PNA; positron emission tomography;
D O I
10.1002/jlcr.522
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Peptide nucleic acids (PNAs) are a unique class of synthetic macromolecules, originally designed as ligands for the recognition of double stranded DNA. From a chemical point of view, the deoxyribose phosphate backbone of DNA is replaced by a pseudo-peptide N-(2-aminoethyl)glycyl backbone, while the nucleobases of DNA (adenine, guanine, cytosine and thymine) are retained. Due to the increasing interest in the labeling of peptide nucleic acids (PNAs) as potent diagnostic agents in nuclear medicine, we have used and adapted the reliable methodology developed for the fluorine-18 labeling of oligonucleotides and have now demonstrated that it is possible to label PNAs in sufficient quantity and with high specific radioactivity for PET studies in a time compatible with the half life of fluorine-18. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 24 条
[1]   PHARMACOKINETICS OF ANTISENSE OLIGONUCLEOTIDES [J].
AGRAWAL, S ;
TEMSAMANI, J ;
GALBRAITH, W ;
TANG, JY .
CLINICAL PHARMACOKINETICS, 1995, 28 (01) :7-16
[2]  
AGRAWAL S, 1996, ANTISENS THERAPEUTIC
[3]   Modified (PNA, 2′-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription [J].
Boulmé, F ;
Freund, F ;
Moreau, S ;
Nielsen, PE ;
Gryaznov, S ;
Toulmé, JJ ;
Litvak, S .
NUCLEIC ACIDS RESEARCH, 1998, 26 (23) :5492-5500
[4]   Comparative pharmacokinetics, tissue distribution, and tumor accumulation of phosphorothioate, phosphorodithioate, and methylphosphonate oligonucleotides in nude mice [J].
DeLong, RK ;
Nolting, A ;
Fisher, M ;
Chen, Q ;
Wickstrom, E ;
Kligshteyn, M ;
Demirdji, S ;
Caruthers, M ;
Juliano, RL .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (02) :71-77
[5]   SEQUENCE SELECTIVE DOUBLE-STRAND DNA CLEAVAGE BY PEPTIDE NUCLEIC-ACID (PNA) TARGETING USING NUCLEASE S1 [J].
DEMIDOV, V ;
FRANKKAMENETSKII, MD ;
EGHOLM, M ;
BUCHARDT, O ;
NIELSEN, PE .
NUCLEIC ACIDS RESEARCH, 1993, 21 (09) :2103-2107
[6]   Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging [J].
Dolci, L ;
Dolle, F ;
Valette, H ;
Vaufrey, F ;
Fuseau, C ;
Bottlaender, M ;
Crouzel, C .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (03) :467-479
[7]   Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine:: A new positron emission tomography ligand for nicotinic receptors [J].
Dollé, F ;
Dolci, L ;
Valette, H ;
Hinnen, F ;
Vaufrey, F ;
Guenther, I ;
Fuseau, C ;
Coulon, C ;
Bottlaender, M ;
Crouzel, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (12) :2251-2259
[8]  
Dolle F, 1997, J LABELLED COMPD RAD, V39, P319, DOI 10.1002/(SICI)1099-1344(199704)39:4<319::AID-JLCR970>3.0.CO
[9]  
2-7
[10]   PEPTIDE NUCLEIC-ACIDS (PNA) - OLIGONUCLEOTIDE ANALOGS WITH AN ACHIRAL PEPTIDE BACKBONE [J].
EGHOLM, M ;
BUCHARDT, O ;
NIELSEN, PE ;
BERG, RH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (05) :1895-1897